Concomitant expression of adrenomedullin and its receptor components in rat adipose tissues

American Journal of Physiology - Endocrinology and Metabolism

Volumn 288, Issue 1 51-1, 2005, Pages

  Fukai, Nozomi ^a   Yoshimoto, Takanobu ^a   Sugiyama, Toru ^a   Ozawa, Naoko ^a   Sato, Ryuji ^a   Shichiri, Masayoshi ^a   Hirata, Yukio ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

3T3 L1 cells; Adipocyte; Obesity

Indexed keywords

ADIPOKINETIC HORMONE; ADIPONECTIN; ADRENOMEDULLIN RECEPTOR; CALCITONIN GENE RELATED PEPTIDE[8-37]; CALCITONIN RECEPTOR LIKE RECEPTOR; PLASMINOGEN ACTIVATOR INHIBITOR;

ADIPOSE TISSUE; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL TYPE; LIPID METABOLISM; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PLEIOTROPY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; RAT; RECEPTOR GENE; RECEPTOR UPREGULATION;

ADIPOCYTES; ADIPOSE TISSUE; ADRENOMEDULLIN; ANIMALS; CELL DIFFERENTIATION; EPIDIDYMIS; GENE EXPRESSION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MICE; NIH 3T3 CELLS; OBESITY; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CALCITONIN; RNA, MESSENGER;

EID: 11144257724     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00586.2003     Document Type: Article

References (38)

1. Elsasser TH and Kahl S. Adrenomedullin has multiple roles in disease stress: development and remission of the inflammatory response. Microsc Res Tech 57: 120-129, 2002.
2. Fruhbeck G, Gomez-Ambrosi J, Muruzabal FJ, and Burrell MA. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab 280: E827-E847, 2001.
3. Fukai N, Shichiri M, Ozawa N, Matsushita M, and Hirata Y. Coexpression of calcitonin receptor-like receptor and receptor activity-modifying protein 2 or 3 mediates the antimigratory effect of adrenomedullin. Endocrinology 144: 447-453, 2003.
4. Garcia-Unzueta MT, Montalban C, Pesquera C, Berrazueta JR, and Amado JA. Plasma adrenomedullin levels in type 1 diabetes. Relationship with clinical parameters. Diabetes Care 21: 999-1003, 1998.
5. Hayashi M, Shimosawa T, Isaka M, Yamada S, Fujita R, and Fujita T. Plasma adrenomedullin in diabetes. Lancet 350: 1449-1450, 1997.
6. Hirata Y, Mitaka C, Sato K, Nagura T, Tsunoda Y, Amaha K, and Marumo F. Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis. J Clin Endocrinol Metab 81: 1449-1453, 1996.
7. Horio T, Kohno M, Kano H, Ikeda M, Yasunari K, Yokokawa K, Minami M, and Takeda T. Adrenomedullin as a novel antimigration factor of vascular smooth muscle cells. Circ Res 77: 660-664, 1995.
8. Hotamisligil GS, Shargill NS, and Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87-91, 1993.
9. Iwasaki H, Eguchi S, Shichiri M, Marumo F, and Hirata Y. Adrenomedullin as a novel growth-promoting factor for cultured vascular smooth muscle cells: role of tyrosine kinase-mediated mitogen-activated protein kinase activation. Endocrinology 139: 3432-3441, 1998.
10. Kahn BB and Flier JS. Obesity and insulin resistance. J Clin Invest 106: 473-481, 2000.
11. Kato H, Shichiri M, Marumo F, and Hirata Y. Adrenomedullin as an autocrine/paracrine apoptosis survival factor for rat endothelial cells. Endocrinology 138: 2615-2620, 1997.
12. Kato J, Kitamura K, Uemura T, Kuwasako K, Kita T, Kangawa K, and Eto T. Plasma levels of adrenomedullin and atrial and brain natriuretic peptides in the general population: their relations to age and pulse pressure. Hypertens Res 25: 887-892, 2002.
13. Kim W, Moon SO, Sung MJ, Kim SH, Lee S, So JN, and Park SK. Angiogenic role of adrenomedullin through activation of Akt, mitogen-activated protein kinase, and focal adhesion kinase in endothelial cells. FASEB J 17: 1937-1939, 2003.
14. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, and Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192: 553-560, 1993.
15. Kubo A, Minamino N, Isumi Y, Katafuchi T, Kangawa K, Dohi K, and Matsuo H. Production of adrenomedullin in macrophage cell line and peritoneal macrophage. J Biol Chem 273: 16730-16738, 1998.
16. Landin K, Stigendal L, Eriksson E, Krotkiewski M, Risberg B, Tengborn L, and Smith U. Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism 39: 1044-1048, 1990.
17. Letizia C, Celi M, Cerci S, Scuro L, Delfini E, Subioli S, Caliumi C, and D'Erasmo E. High circulating levels of adrenomedullin and endothelin-1 in obesity associated with arterial hypertension. Ital Heart J 2: 1011-1015, 2001.
18. Li J, Yu X, Pan W, and Unger RH. Gene expression profile of rat adipose tissue at the onset of high-fat-diet obesity. Am J Physiol Endocrinol Metab 282: E1334-E1341, 2002.
19. Li Y, Totsune K, Takeda K, Furuyama K, Shibahara S, and Takahashi K. Decreased expression of adrenomedullin during adipocyte-differentiation of 3T3-L1 cells. Hypertens Res 26: S41-S44, 2003.
20. Li Y, Totsune K, Takeda K, Furuyama K, Shibahara S, and Takahashi K. Differential expression of adrenomedullin and resistin in 3T3-L1 adipocytes treated with tumor necrosis factor-alpha. Eur J Endocrinol 149: 231-238, 2003.
21. Martinez A, Elsasser TH, Bhathena SJ, Pio R, Buchanan TA, Macri CJ, and Cuttitta F. Is adrenomedullin a causal agent in some cases of type 2 diabetes? Peptides 20: 1471-1478, 1999.
22. Martinez A, Weaver C, Lopez J, Bhathena SJ, Elsasser TH, Miller MJ, Moody TW, Unsworth EJ, and Cuttitta F. Regulation of insulin secretion and blood glucose metabolism by adrenomedullin. Endocrinology 137: 2626-2632, 1996.
23. Matsumoto S, Kishida K, Shimomura I, Maeda N, Nagaretani H, Matsuda M, Nishizawa H, Kihara S, Funahashi T, Matsuzawa Y, Yamada A, Yamashita S, Tamura S, and Kawata S. Increased plasma HB-EGF associated with obesity and coronary artery disease. Biochem Biophys Res Commun 292: 781-786, 2002.
24. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, and Foord SM. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393: 333-339, 1998.
25. Minami J, Nishikimi T, Ishimitsu T, Makino Y, Kawano Y, Takishita S, Kangawa K, and Matsuoka H. Effect of a hypocaloric diet on adrenomedullin and natriuretic peptides in obese patients with essential hypertension. J Cardiovasc Pharmacol 36: S83-S86, 2000.
26. Minamino N, Kikumoto K, and Isumi Y. Regulation of adrenomedullin expression and release. Microsc Res Tech 57: 28-39, 2002.
27. Nakamura T, Honda K, Ishikawa S, Kitamura K, Eto T, and Saito T. Plasma adrenomedullin levels in patients with non-insulin dependent diabetes mellitus: close relationships with diabetic complications. Endocr J 45: 241-246, 1998.
28. Nussdorfer GG, Rossi GP, and Mazzocchi G. Role of adrenomedullin and related peptides in the regulation of the hypothalamo-pituitary-adrenal axis. Peptides 18: 1079-1089, 1997.
29. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, and Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269: 540-543, 1995.
30. Saye JA, Cassis LA, Sturgill TW, Lynch KR, and Peach MJ. Angiotensinogen gene expression in 3T3-L1 cells. Am J Physiol Cell Physiol 256: C448-C451, 1989.
31. Shichiri M, Fukai N, Ozawa N, Iwasaki H, and Hirata Y. Adrenomedullin is an autocrine/paracrine growth factor for rat vascular smooth muscle cells. Regul Pept 112: 167-173, 2003.
32. Shichiri M and Hirata Y. Antiangiogenesis signals by endostatin. FASEB J 15: 1044-1053, 2001.
33. Shimosawa T, Ogihara T, Matsui H, Asano T, Ando K, and Fujita T. Deficiency of adrenomedullin induces insulin resistance by increasing oxidative stress. Hypertension 41: 1080-1085, 2003.
34. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, and Lazar MA. The hormone resistin links obesity to diabetes. Nature 409: 307-312, 2001.
35. Suzuki Y, Horio T, Hayashi T, Nonogi H, Kitamura K, Eto T, Kangawa K, Kawano Y, Hagi-Pavli E, Farthing PM, Kapas S, Elsasser TH, Kahl S, Kubo A, Minamino N, Isumi Y, Katafuchi T, Dohi K, and Matsuo H. Plasma adrenomedullin concentration is increased in patients with peripheral arterial occlusive disease associated with vascular inflammation. Regul Pept 118: 99-104, 2004.
36. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, and Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796-1808, 2003.
37. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H, Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, and Ferrante AW Jr. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112: 1821-1830, 2003.
38. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, and Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7: 941-946, 2001.